Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...
The FDA Cracks Down On Stem Cell Therapy.
Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold...
Citius (CTXR): Halt For Superiority On The Horizon? (SeekingAlpha).
Jun. 15, 2021 10:41 AM ET Citius Pharmaceuticals, Inc. (CTXR)
Summary
More Great News From Citius Pharma (CTXR).
UPDATED CHART 6-15-21
Mino-Lok® Phase III, FDA NewsRussell 2000 Index NewsTechnical Breakout News
Stocks On The Move!
Citius (CTXR) up 19%, Draganfly (DFLYF) up 31%, urban-gro (UGRO) up 37%, Provention (PVRB) flip-flopping, Hapbee Technologies (HAPBF) up 26% and the...
Discontinuing Coverage on Dalrada (DFCO).
We Are Temporarily Discontinuing Coverage on Dalrada Financial.
Great little company and we're up 400%. But with the market...
Citius Pharma (CTXR) Updates Shareholders.
Citius Update Stem Cell Study
Citius Pharmaceuticals, Inc announced that it will present a poster at the International Society...
Old News, But Wow: Starr Foundation Reaffirms Support for Stem Cell Research with $50...
Someone is a Big Believer and Cutting Equally Big Checks!
NEW YORK (April 4, 2019) — The Starr...
Stem Cell Play Organicell (BPSR) Screams Higher.
Stock Levitates After Series of Positive Press Releases on Zofrin.
Added to the Watch List in April a...
Interview: Citius Pharma (CTXR) $1.74, Chairman Leonard Mazur.
https://youtu.be/vMIy8xWLOKI?t=3699
Starts at 1 Hour Mark.
INSIDER HOLDINGS
Latest article
Hapbee’s (HAPB) Revolutionary Sleep Aid Lands on the Shelves of Target.
When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the "highest potential...
Adding Cybin (CYBN) to 2024 Top Psychedelic Stocks Watch List.
Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.
ENDRA Life Science’s (NDRA) $1.23 Fatty Liver Detector Advances to Next Stage of Review...
Gentleman start your engines!
Endra (NDRA) recently announced it has advanced to 'substantive review*' with the U.S. Food...
